DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Open accessThe DOI matches its Crossref record; 84 of the 86 references it cites were found in a registry or an index.
Abstract
Senescent vascular smooth muscle cells (VSMCs) accumulate in the vasculature with age and tissue damage and secrete factors that promote atherosclerotic plaque vulnerability and disease. Here, we report increased levels and activity of dipeptidyl peptidase 4 (DPP4), a serine protease, in senescent VSMCs. Analysis of the conditioned media from senescent VSMCs revealed a unique senescence-associated secretory phenotype (SASP) signature comprising many complement and coagulation factors; silencing or inhibiting DPP4 reduced these factors and increased cell death. Serum samples from persons with high risk for cardiovascular disease contained high levels of DPP4-regulated complement and coagulation factors. Importantly, DPP4 inhibition reduced senescent cell burden and coagulation and improved plaque stability, while single-cell resolution of senescent VSMCs reflected the senomorphic and senolytic effects of DPP4 inhibition in murine atherosclerosis. We propose that DPP4-regulated factors could be exploited therapeutically to reduce senescent cell function, reverse senohemostasis, and improve vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Senescent hVSMCS secrete procoagulation and complement factors that are suppressed by DPP4 inhibition. (A) Schematic depicting the experimental setup for mass spectrometry analysis of the media of proliferating and senescent hVSMCs treated with and without DPP4i. (B) Volcano plot of the proteins increased (red) and decreased (blue) in senescent hVSMCs compared with proliferating hVSMCs. Proteins in red and blue have a significance (–log10 adjusted P value [Padj]) ≥2. (C) Heatmap of the complement and coagulation proteins in each CoCl2 and Doxo replicate (n = 3) compared with the mean of the proliferating control for each protein. (D) Top 10 pathways enriched using BioPlanet pathway analysis ranked by combined score in senescent hVSMCs. (E) Reactome pathway analysis as ranked by combined score representative of the top elevated proteins in senescent hVSMCs. (F) STRING functional protein association network analysis to determine protein interactions among the top elevated proteins in senescent hVSMCs. (G) Volcano plot of proteins increased (red) and decreased (blue) after DPP4i treatment of senescent hVSMCs. Proteins in red and blue have a significance (–log10 Padj) ≥ 1. (H) Heatmap of complement and coagulation proteins in senescent hVSMCs (mean of CoCl2 and Doxo replicates, n = 3) compared with senescent hVSMCs treated with DPP4i (mean of CoCl2 and Doxo replicates). (I) Schematic depiction of senescence induction in hVSMCs causing increased complement and coagulation protein secretion, which is attenuated by DPP4i treatment as determined by mass spectrometry of secreted proteins in the media.](https://figures.cochat.ai/paper-figures/18e4172058814f2ca38f15ba11034aaa/dpp4-inhibition-impairs-senohemostasis-to-improve-plaque-stability-in-figure-4.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, SASP-associated complement and coagulation signaling pathways were recently linked to senescence, particularly in vascular cells, for which they are critical for cell survival20,21.”
From Single-cell and spatial transcriptomics map senescent vascular cells in arterial remodeling during atherosclerosis in mice (2025) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Senescent cells also display a senescence-associated β -galactosidase (SA– β -gal) activity (5, 6).”
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“While senescent cells possess beneficial functions in certain contexts, such as wound healing or development, there is overwhelming evidence that the accumulation of senescent cells in age-related diseases contributes to disease development or progression (50).”
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605 · cited 1×
“Senescent cells also display a senescence-associated β -galactosidase (SA– β -gal) activity (5, 6).”
Senolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Research works printed but not linked: 2
- 10.1210/jcem.86.2.7219 · DOI · Paper page
- 10.1016/j.cell.2021.04.048 · doi:10.1016/j.cell.2021.04.048 · Paper page
Cited by
Current senolytics: Mode of action, efficacy and limitations, and their future
Rad, A. N., & Grillari, J. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111888 · Cited by 83
Mazan-Mamczarz, K., Tsitsipatis, D., Childs, B. G., Carr, A. E., Dos Santos, C. R., Anerillas, C., Romero, B., Gregg, J. M., Henry-Smith, C., Okereke, A. N., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00889-z · Cited by 48
“In addition, SASP-associated complement and coagulation signaling pathways were recently linked to senescence, particularly in vascular cells, for which they are critical for cell survival 20,21 .”
Self-citationThe complement system in lipid-mediated pathologies
Alić, L., Dendinovic, K., & Papac-Miličević, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1511886 · Cited by 20
Mahoney, S. A., Dey, A. K., Basisty, N., & Herman, A. B. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00352.2023 · Cited by 21
Self-citationKról, M., Kupnicka, P., Żychowska, J., Kapczuk, P., Szućko-Kociuba, I., Prajwos, E., & Chlubek, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146777 · Cited by 19
“Additionally, DPP-4i reduced foam cell formation of macrophages isolated from T1D mice and patients [90] and mitigated inflammation [38] and plaque instability in in vivo studies [91].”
Targeting senescent cells in atherosclerosis: Pathways to novel therapies
Tian, Y., Shao, S., Feng, H., Zeng, R., Li, S., & Zhang, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102502 · Cited by 16
Wnuk, M., Sol‐Fernández, S. D., Błoniarz, D., Słaby, J., Szmatoła, T., Żebrowski, M., Martínez‐Vicente, P., Litwinienko, G., Moros, M., & Lewińska, A. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00771 · Cited by 14
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Dey, A. K., Banarjee, R., Boroumand, M., Rutherford, D. V., Strassheim, Q., Nyunt, T., Olinger, B., & Basisty, N. (2023) · Biology · doi:10.3390/biology12101301 · Cited by 14
“A subsequent study demonstrated that senescence-associated DPP4 activity can be pharmacologically targeted to improve hemostasis and plaque stability in old mice [192].”
BackgroundCai, J., Ge, X., Lu, S., Wang, Y., Cui, H., Zhan, R., Su, S., Shan, W., Cai, Z., Wu, C., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202406192 · Cited by 14
Advances in small-molecule insulin secretagogues for diabetes treatment
Su, J., Xu, J., Hu, S., Ye, H., Xie, L. N., & Ouyang, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117179 · Cited by 20
Molecular damage associated with ageing drives inflammation in cardiovascular disease
Herman, A. B., Candia, J., Wilson, D. M., Donegà, S., Picard, M. A., & Ferrucci, L. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01253-3 · Cited by 17
“Senescent VSMCs secrete typical SASP factors, such as IL-1β and IL-6, as well as complement and coagulation factors, which contribute to plaque vulnerability and perpetuate inflammation 36,37 .”
Self-citationIdentification of senescent cell subpopulations by CITE ‐seq analysis
Abdelmohsen, K., Mazan-Mamczarz, K., Munk, R. B., Tsitsipatis, D., Meng, Q., Rossi, M. S., Pal, A., Shin, C. H., Martindale, J. L., Piao, Y., et al. (2024) · Aging Cell · doi:10.1111/acel.14297 · Cited by 14
“One subpopulation displayed high cell-surface levels of CD109 and CD112 proteins (cluster 3), the other subpopulation exhibited high cell-surface levels of CD112, CD26, CD73, HLA-ABC, CD54, CD49A, and CD44 proteins (cluster 0).”
InfluentialSelf-citationXia, B., Liang, J., Lu, Y., Ding, J., Peng, J., Li, F., Dai, J., Liu, Y., Wang, J., Wan, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-95181-w · Cited by 21
“…factors promote vascular inflammation, increase the risk of intraplaque hemorrhage, and promote inflammatory cell infiltration to destabilize coronary plaques, and that an increase in anti-inflammatory factors leads to an inflammatory imbalance that exacerbates atherosclerosis 31–33 .”
Self-citationHSPB1 suppresses oxLDL-induced vascular smooth muscle cell ferroptosis by inhibiting DPP4
Li, Y., Zhang, L., Zhang, Q., Zhang, Y., Pan, S., Zhao, H., & Zhang, L. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110400 · Cited by 9
Zhang, G., Li, L., Yang, Z., Zhang, C., & Kang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713236 · Cited by 11
D ipeptidylpeptidase‐4‐targeted activatable fluorescent probes visualize senescent cells
Tanaka, H., Sugawara, S., Tanaka, Y., Loo, T. M., Tachibana, R., Abe, A., Kamiya, M., Urano, Y., & Takahashi, A. (2024) · Cancer Science · doi:10.1111/cas.16229 · Cited by 7
“24,40,41 44 Moreover, anti-DPP4 Abs 25 and polymers conjugated to a DPP4 inhibitor 45 senescent cells.”
BackgroundGSDME-dependent pyroptosis drives abdominal aortic aneurysm via promoting vascular senescence
Sun, S.-J., Zhang, Z., Zhang, G., Wu, J., Zhang, Y.-X., Wu, W., Zhang, Y., Yin, H. H., Zhang, J., Cao, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66103-1 · Cited by 12
Self-citationHamada, N., Kawano, K.-I., Hirota, S., Yusoff, F. M., Nomura, T., Saito, Y., Nakashima, A., Yoshinaga, S., & Higashi, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-92710-5 · Cited by 6
Integration of Vascular Smooth Muscle Cell Phenotypic Switching and Senescence
Deng, S., Yin, X., & Zhu, R. (2025) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001752 · Cited by 8
Senescence: An Overlooked VSMC Phenotype and Therapeutic Opportunity?
Herman, A. B., Grešová, K., Maragkakis, M., & Autieri, M. V. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323131 · Cited by 9
Self-citationSłaby, J., Wnuk, M., Błoniarz, D., Stec, P., Szmatoła, T., Kaznowska, E. B., Reich, A., Moros, M., & Lewińska, A. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04028-w · Cited by 7
“…noting that CD26 has been already proposed as a senescence-associated marker in different normal cells such as fibroblasts, mesenchymal stromal cells, vascular smooth muscle cells and various lung cell types (Kim et al. 2017; Psaroudis et al. 2022; Herman et al. 2023; Deinhardt-Emmer et al. 2023).”
Escriche‐Navarro, B., Garrido, E., Escudero, A. C., Montoya-Méndez, I., Sancenón, F., García‐Fernández, A., & Martínez‐Máñez, R. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123461 · Cited by 7
DPP4-regulated endothelial cell ferroptosis modulates atherosclerosis progression by ferritinophagy
Zheng, L., Liang, K., Peng, Y., Jin, M., Chen, X., Liu, X., Shao, H., Zhang, T., Duan, J., Yan, F., et al. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.01.006 · Cited by 5
Elemary, T., Nicola, M., Abdelrahim, M. E. A., & Zaafar, D. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10458-7 · Cited by 6
Yen, I., & Li, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14100 · Cited by 4
“First, the DPP4 inhibitor used in the study 1 , vildagliptin, did not have a cardiovascular outcome trial in humans.”
BackgroundMethodResultInfluentialCharacterizing the SASP ‐Dependent Paracrine Spreading of Senescence Between Human Brain Cell Types
Russo, T., & Rießland, M. (2026) · Aging Cell · doi:10.1111/acel.70673 · Cited by 4
Fu, Q., & Zhang, S. (2025) · Medicine · doi:10.1097/md.0000000000042601 · Cited by 4
“…transduction processes, regulating the proliferation and migration of vascular smooth muscle cells, which is a key link in the development of AS. [20] Therefore, the expression changes of the key diagnostic genes identified in this study may be potentially associated with the oxidative stress…”
Zhou, Y., Matsumura, T., Saito, S., Yagi, Y., Yoshinaga, T., Takeshita, M., Fukuda, K., Senokuchi, T., Motoshima, H., Kondo, T., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.153037 · Cited by 2
Artery tertiary lymphoid organs, neuro-immune interaction and their mediators in atherosclerosis
Ortona, S., Ivaldo, C., Liberale, L., Carbone, F., Montecucco, F., Bastianon, M., Mastrogiacomo, M., Palombo, D., Pratesi, G., & Barisione, C. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01164-x · Cited by 4
“…been demonstrated that inhibition of dipeptidyl peptidase 4, a serine protease overexpressed in senescent VSMCs from atherosclerotic lesions, counteracts the release of pro-inflammatory and pro-thrombotic factors and increases senescent cell death, improving the overall vascular performance [39].”
Syed, A., Aloti, R. A., Awad, B. J., Alghoul, W. I. I., Hassan, M. A. M. S. A., Kharoufeh, A., & Rangraze, I. R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1799261 · Cited by 3
Chen, Y., Kraus, V. B., Chang, Y., Lin, T.-M., Lee, H.-Y., Chang, C., Kuo, T., Chen, J.-H., & Chang, C. (2026) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x261434279 · Cited by 3
“12,13 Such properties have raised interest in repurposing DPP-4is for conditions beyond diabetes management.”
Tsitsipatis, D., Rivera, T. R., Kaileh, M., Okereke, A. N., Gupta, A., Singh, A., Raph, S. M., Henry-Smith, C., & Herman, A. B. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.324299 · Cited by 2
“4 Senescent VSMCs may also reduce oxLDL uptake capabilities as a protective mechanism to remain viable or prevent further cellular damage, though this should be investigated further.”
Self-citationCellular senescence as a systems-level driver of cardiovascular ageing
Wang, M.-M., Liu, T., Xu, C.-Q., Zhong, Y.-L., Liang, Z.-Q., Li, J., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103175 · Cited by 4
Self-citationWei, Y., Liao, Y., Zhang, C., & Guo, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1844567 · Cited by 2
“Senescent VSMCs upregulate dipeptidyl peptidase 4 to cleave coagulation factor X and activate the PAR2 receptor, thereby igniting intense vascular in fl ammation (88).”
Ng, S., Kao, S.-W., Chen, C. C., Lin, S.-Z., Hsieh, D. J., Kuo, C., Lin, K., Huang, C., & Kuo, W. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08445-y · Cited by 2
“Previous studies have indicated that several transcription factors (TFs), including SP1, FOS, and NFκB, may bind to the DPP4 promoter [29, 30].”
Nobiletin regulates the proliferation and migration of ovarian cancer A2780 cells via DPP4 and TXNIP
He, X., Dou, L., Wang, J., Xia, L., JiaWei, M., & Yan, Y. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03334-x · Cited by 2
“Dipeptidyl peptidase 4 ( DPP4 ), also called ADCP2 or CD26 , is a glycoprotein widely distributed across various tissues and cell membrane surfaces (Wang et al. 2023; Herman et al. 2023), with a key role in metabolism and immunity.”
Mazan-Mamczarz, K., Tsitsipatis, D., Carr, A. E., Childs, B. G., Santos, C. R. D., Anerillas, C., Romero, B., Gregg, J. M., Michel, M., Munk, R. B., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3235572/v1 · Cited by 2
Self-citationDissecting the Heterogeneity of Senescent Cells Through CITE-seq Integration
Abdelmohsen, K., Mazan-Mamczarz, K., Tsitsipatis, D., Rossi, M. S., Munk, R. B., & Gorospe, M. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4434-8_7 · Cited by 3
Self-citationManni, E., Al‐kuraishy, H. M., Fawzy, M. N., & Batiha, G. E. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05416-4 · Cited by 1
“In the atherosclerotic mouse model, the administration of the DPP4 inhibitor led to a reduction in SASP expression and a decrease in the quantity of senescent cells in the aorta, as well as an enhancement in plaque stability (Herman et al. 2023).”
Li, J. N., Hu, X., Guo, C., Xue, W., Wu, J., Yang, M., Wang, J., Qiao, J., Zhu, X., Meng, L., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120456 · Cited by 1
Lee, H. J., & Chun, P. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.12.005
Dotou, M. (2023) · theses.fr (ABES) · doi:10.70675/ea22a042z96ccz45fdz9667z82a8825cb567
CD8+ T cells in atherosclerosis and coronary artery disease
Tandon, I., yosri, M., Soliman, H., Khalifa, A. M., Ley, K. F., & Abdelsamed, H. A. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01295-7 · Cited by 2
Inflammation in atherosclerosis: Drivers, mechanisms and therapies
Su, Z., & Xu, S. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.047 · Cited by 1
“Plaque destabilization involves dipeptidyl peptidase 4 (DPP4)-mediated VSMC senescence and immune recruitment via complement factors 62 , while Von Willebrand factor (VWF) deposition promotes VSMC proliferation and neointimal hyperplasia through LDL Receptor-related Protein 4 (LRP4) binding and α v…”
Hua, R., Kang, X., Peng, H., Liu, K., Long, N., Zeng, C., Wang, Y., Guo, Y., & Wang, Z. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.054
“Silencing or inhibiting Dpp4 reduces the senescence-associated secretory phenotype (SASP) signature and increases cell death in senescent vascular smooth muscle cells, improving vascular disease 7 .”
The senescence–immune axis as a target for combining immunotherapy and senotherapy
Saez‐Calazans, F., Grün, L. K., Stein, L. E., Barbé‐Tuana, F. M., & Filippi‐Chiela, E. C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103309
Cui, H., Nisar, A., Duan, Z., Mao, J., Zhu, H., Li, L., Cao, X., He, Y., & Li, W. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108443
Li, H., Song, A., Zhang, J., Dong, H., Li, X., & Zhao, Y. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07956-6
Self-citationSancar, N., Özaydın, Ş., Emekli, A. S., Yılmaz, V., Türkoğlu, R., & Tüzün, E. (2026) · Neurological Research · doi:10.1080/01616412.2026.2746401
The Aging Extracellular Matrix as a Driver of Vascular Reprogramming
Shalash, R., Tsitsipatis, D., & Herman, A. B. (2026) · Artery Research · doi:10.1007/s44200-026-00144-9
“Notably, earlier reports on the clearance of senescent cells in p16-3MR or vildagliptin-treated atherosclerotic mice similarly altered the ECM deposition [165, 166]; vildagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP4), a protein highly expressed on the surface of senescent VSMCs [167].”
Self-citation
Metadata
- Authors
- Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., Harris, S. C., Munk, R., Martindale, J. L., Piao, Y., Fan, J., Mattison, J. A., De, S., Abdelmohsen, K., Maul, R. W., Tanaka, T., Moore, A. Z., DeMouth, M. E., Sidoli, S., Ferrucci, L., Liu, Y., de Cabo, R., Lakatta, E. G., & Gorospe, M.
- Affiliations
- National Institutes of Health (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Herman, Allison B.
- ORCID
- Herman, Allison B.
- Tsitsipatis, Dimitrios
- Anerillas, Carlos
- Mazan-Mamczarz, Krystyna
- Carr, Angelica E.
- Gregg, Jordan M.
- Wang, Mingyi
- Munk, Rachel
- Martindale, Jennifer L.
- Fan, Jinshui
- Mattison, Julie A.
- De, Supriyo
- Abdelmohsen, Kotb
- Maul, Robert W.
- Tanaka, Toshiko
- Moore, Ann Zenobia
- DeMouth, Megan E.
- Sidoli, Simone
- Ferrucci, Luigi
- Liu, Yie
- de Cabo, Rafael
- Lakatta, Edward G.
- Gorospe, Myriam
- Venue
- Journal of Clinical Investigation
- Published
- 2023-06-15
- Volume
- 133
- Issue
- 12
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10266795
- OpenAlex
- W4366983099
- Cited by
- 50
- References
- 86
- Citations by year
- 2026: 20 · 2025: 15 · 2024: 8 · 2023: 7
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (1s10od030286-01)
- National Institute on Aging
- National Cancer Institute (P30CA013330)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Keywords
- dipeptidyl peptidase IV, DPP-4 inhibition, vascular smooth muscle cell senescence, senescence-associated secretory phenotype, atherosclerotic plaque stability, complement proteins, coagulation factors, senolytic therapy, cardiovascular risk
- MeSH terms
- Animals, Muscle, Smooth, Vascular, Cellular Senescence, Dipeptidyl Peptidase 4, Atherosclerosis, Mice, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.